These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25808733)

  • 1. Bisphosphonate exposure and osteonecrosis of the jaw.
    Hatton RC; Patel P; Liu W
    J Bone Miner Res; 2015 Apr; 30(4):748. PubMed ID: 25808733
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate exposure and osteonecrosis of the jaw.
    Borromeo GL; Brand C; Clement JG; McCullough M; Crighton L; Hepworth G; Wark JD
    J Bone Miner Res; 2015 Apr; 30(4):749-50. PubMed ID: 25808734
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
    Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
    Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.
    Borromeo GL; Brand C; Clement JG; McCullough M; Thomson W; Flitzanis E; Wark JD
    BMC Musculoskelet Disord; 2011 Apr; 12():71. PubMed ID: 21477374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate.
    Badel T; Pavicin IS; Carek AJ; Rosin-Grget K; Grbesa D
    Coll Antropol; 2013 Jun; 37(2):645-51. PubMed ID: 23941019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw as a serious adverse effect of bisphosphonate therapy and its indistinct etiopathogenesis.
    Gavrić M; Antić S; Jelovac DB; Zarev AI; Petrović MB; Golubović M; Antunović M
    Vojnosanit Pregl; 2014 Aug; 71(8):772-6. PubMed ID: 25181838
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

  • 11. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
    Li YF; Hu J
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
    Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
    J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating osteoporosis.
    Smith G; Stassen L; Flint S
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing medication-related osteonecrosis of the jaw.
    Zebic L; Patel V
    BMJ; 2019 May; 365():l1733. PubMed ID: 31068319
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.
    Allen MR
    Odontology; 2011 Jan; 99(1):8-17. PubMed ID: 21271320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
    Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.